Zobrazeno 1 - 10
of 643
pro vyhledávání: '"Y. Neron"'
Autor:
Blázquez, José Maria
Publikováno v:
Latomus, 2011 Mar 01. 70(1), 276-278.
Externí odkaz:
http://www.jstor.org/stable/41546843
Autor:
C. Mathias, Tomás Reinert, José Bines, Facundo Zaffaroni, Ruffo Freitas Junior, Sergio Daniel Simon, Geraldo Silva Queiroz, G. Borges, H Resende, RdC Costamilan, D de Andrade, Kissya Kropf da Silva, K Emerenciano, Daniela Dornelles Rosa, V Dybal, VC Cordeiro de Lima, Eduardo Cronemberger, Nicolas Lazaretti, Gustavo Werutsky, Alessandra Morelle, Y. Neron, Carlos Barrios, Maria Alice Franzoi, J Couto, Max S. Mano, P Liedke, G Zerwes Vacaro, CA Sampaio Filho, Susanne Crocamo, B Van Evyl
Publikováno v:
Cancer Research. 79:P1-08
BACKGROUND: Breast cancer (BC) in young women is uncommon and often more aggressive. There are disparities in terms of screening coverage, diagnostic features and access to optimal treatment among young BC patients worldwide. To better understand thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b472f2a12f51bd4edd34245936677e2c
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-27
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-27
Autor:
Vladmir Cláudio Cordeiro de Lima, CA Sampaio Filho, Susanne Crocamo, Rita de Cassia Costamilan, Ruffo Freitas-Junior, G. Borges, Max S. Mano, Kátia Luz Torres, Giovana Zerwes Vacaro, Y. Neron, Diocésio Alves Pinto de Andrade, Nicolas Lazaretti, V Dybal, C. Mathias, H Resende, G Werustky, Sergio Daniel Simon, Alessandra Morelle, K Emerenciano, Carlos Barrios, Eduardo Cronemberger, J Couto, Daniela Dornelles Rosa, José Bines, Facundo Zaffaroni, Tomás Reinert, Geraldo Silva Queiroz, B Van Eyil
Publikováno v:
Cancer Research. 79:P1-08
BACKGROUND Breast cancer (BC) is the most common tumor in women in Brazil with about 60 thousand new cases estimated per year. In low and middle-income countries, patients with BC are diagnosed with more advanced stages as compared with high-income c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc385065d7eb37602772116b5e254ee0
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-29
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-29
Autor:
Sergio Daniel Simon, Eduardo Cronemberger, Gustavo Werutsky, Carlos Sampaio Filho, Rita de Cassia Costamilan, Y. Neron, H Resende, Ruffo Freitas-Junior, C. Mathias, Susane Crocamo, Vladmir Cláudio Cordeiro de Lima, Daniela Dornelles Rosa, Rafaela Gomes de Jesus, Giovana Zerwes Vacaro, José Bines, V Dybal, Diocésio Alves Pinto de Andrade, G. Borges, Brigitte Van Eyil, Nicolas Lazaretti, Tomás Reinert, K Emerenciano, J Couto, Carlos Barrios, Alessandra Morelle, Maira Caleffi, Facundo Zaffaroni, Geraldo Silva Queiroz, Max S. Mano
Publikováno v:
Breast cancer research and treatment. 183(3)
In Brazil, the available cancer registries are deficient in number and quality and, hence, little information is known regarding sociodemographic, clinicopathological characteristics, treatment patterns, and outcomes of breast cancer (BC) patients. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9758771e739862b6b75e3e9afadff061
https://pubmed.ncbi.nlm.nih.gov/32728860
https://pubmed.ncbi.nlm.nih.gov/32728860
Autor:
José Bines, Clarissa Gondim Picanço de Albuquerque, Gustavo Werutsky, Carlos Barrios, Gustavo Ismael, A Azambuja, Diocésio Alves Pinto de Andrade, RS Goés, M Debiasi, Y. Neron, Mlm Batista, PX Santi, CA Beato, P Liedke, V Dybal, Daniela Dornelles Rosa, J Giacomazzi, LV dos Santos, Jeovany Martínez-Mesa, G. Borges, D Uema, VC Cordeiro de Lima, Facundo Zaffaroni, RO de Sant'ana, E Cronenberger
Publikováno v:
Cancer Research. 78:P1-17
Background The incidence of brain metastases among women with metastatic breast cancer (MBC) ranges from 10 to 30% depending of breast cancer (BC) subtype. Inequities in the access to optimal treatment and shorter survival of BC by type of health car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9bb0fb54e790478715dad0376229702
https://doi.org/10.1158/1538-7445.sabcs17-p1-17-10
https://doi.org/10.1158/1538-7445.sabcs17-p1-17-10
Autor:
Gustavo Ismael, VC Cordeiro de Lima, M Debiasi, José Bines, Carlos Barrios, PX Santi, Facundo Zaffaroni, LV dos Santos, CA Beato, J Giacomazzi, Jeovany Martínez-Mesa, D Uema, P Liedke, RO de Sant'ana, G. Borges, E Cronenberger, Diocésio Alves Pinto de Andrade, Daniela Dornelles Rosa, V Dybal, RS Goés, Y. Neron, Gustavo Werutsky, A Azambuja, Mlm Batista
Publikováno v:
Cancer Research. 78:P4-10
Background Metastatic breast cancer (MBC) is an incurable disease in which latest therapies have evolving and improving patients survival. Inequities in the access to optimal treatment and shorter survival of BC by type of health care coverage were p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff58d4bb69e15eba8f7079a64f01705d
https://doi.org/10.1158/1538-7445.sabcs17-p4-10-17
https://doi.org/10.1158/1538-7445.sabcs17-p4-10-17
Autor:
CA Beato, A Azambuja, Giselle Gomes Borges, Carlos Barrios, Max S. Mano, Daniela Dornelles Rosa, Gustavo Ismael, LV dos Santos, Y. Neron, Facundo Zaffaroni, José Bines, P Liedke, Gustavo Werutsky, Vitória Regina Oliveira de Lima, RO de Sant'ana, E Cronenberger, Jeovany Martínez-Mesa, D Uema, V Dybal, Mlm Batista, J Giacomazzi, Diocesio Alves Pinto de Andrade
Publikováno v:
Cancer Research. 77:P6-16
Background Randomised clinical trials (RCT) are considered a gold standard generating efficacy and safety data supporting drug approval. However, real world data (RWD) reflecting health care delivery is becoming increasingly important. RWD on patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94584bff3d79770ed2c9c273c376f247
https://doi.org/10.1158/1538-7445.sabcs16-p6-16-04
https://doi.org/10.1158/1538-7445.sabcs16-p6-16-04
Autor:
Vladmir Cláudio Cordeiro de Lima, Y. Neron, Diocésio Alves Pinto de Andrade, Nicolas Lazaretti, Daniela Dornelles Rosa, G. Borges, Alessandra Morelle, Carlos Barrios, H Resende, Susanne Crocamo, Tomás Reinert, V Dybal, José Bines, Ruffo Freitas Junior, Gustavo Werutsky, Eduardo Cronemberger, Max S. Mano, Rita de Cassia Costamillan, Carlos Alberto Sampaio Filho, J Couto, Giovana Zerwes Vacaro, K Emerenciano, Pedro E.R. Liedke, Facundo Zaffaroni, Geraldo Silva Queiroz, Maria Alice Franzoi, Brigitte Van Eyli, Sergio Daniel Simon, C. Mathias
Publikováno v:
Journal of Global Oncology, 5
Journal of Global Oncology
Journal of Global Oncology, Vol 5, Pp 1-10 (2019)
Journal of Global Oncology
Journal of Global Oncology, Vol 5, Pp 1-10 (2019)
PURPOSE: Breast cancer (BC) in young women is uncommon and tends to present with more aggressive characteristics. To better understand and characterize this scenario in Brazil through real-world data, we performed a subanalysis of AMAZONA III study (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6798d70855fd3f37000702943b9909
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296501
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296501
Autor:
Nicolas Lazaretti, Ruffo Freitas-Junior, Brigitte M. Van Eyll, Susanne Crocamo Ventilari Da Costa, H Resende, José Bines, Vladmir Cláudio Cordeiro de Lima, Taiane F Rebelatto, Carla Pavei, Pedro E.R. Liedke, Daniela Dornelles Rosa, Carlos H. Barrios, Geraldo Silva Queiroz, Eduardo Cronemberger, Vanessa Dybal Bertoni, Tomás Reinert, Sergio Daniel Simon, Y. Neron, Rafaela Gomes, Gustavo Werutsky
Publikováno v:
Journal of Clinical Oncology. 39:e12603-e12603
e12603 Background: Breast cancer (BC) is the most common invasive cancer diagnosed in women worldwide. The risk of developing BC increases with age. Studies have shown that approximately up to half of BC cases occur in patients aged 65 years and olde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb2a1c258414317962fa1d1fe4557032
https://doi.org/10.1200/jco.2021.39.15_suppl.e12603
https://doi.org/10.1200/jco.2021.39.15_suppl.e12603
Autor:
José Bines, Jeovany Martínez-Mesa, C Sampaio, Carlos Barrios, Silvia P. Neciosup, C. Blajman, C Tosello, H Pinczowsky, Varela, A Capo, Gustavo Ismael, Max S. Mano, J. J. Zarba, PX Santi, M Fanelli, Luis Fein, Henry L. Gomez, G. Lerzo, Gustavo Werutsky, Y. Neron
Publikováno v:
Cancer Research. 73:P4-12
Background: Lapatinib-Capecitabine (LC) is approved for the treatment of advanced or metastatic breast cancer (MBC) whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane (T), and trastuzumab (H). LACOG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9d57f6af000eaad438509fb6d9e0057
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-26
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-26